# TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM

> **NCT03780569** · NA · UNKNOWN · sponsor: **NovoCure Ltd.** · enrollment: 10 (estimated)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **DEVICE:** NovoTTF-200A
- **RADIATION:** Radiotherapy
- **DRUG:** Temozolomide

## Key facts

- **NCT ID:** NCT03780569
- **Lead sponsor:** NovoCure Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-27
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2018-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03780569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03780569, "TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03780569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*